Clinical Trial
doi: 10.1007/BF00422146.
A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety
- PMID: 4586902
- DOI: 10.1007/BF00422146
Item in Clipboard
Clinical Trial
A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety
Psychopharmacologia.
.
No abstract available
Similar articles
-
A clinical trial of phenelzine in anxiety depressive and phobic neuroses.Br J Psychiatry. 1977 Nov;131:486-92. doi: 10.1192/bjp.131.5.486. Br J Psychiatry. 1977. PMID: 338081 Clinical Trial.
-
Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.J Clin Psychiatry. 1987 Feb;48(2):55-9. J Clin Psychiatry. 1987. PMID: 3542985 Clinical Trial.
-
Phenelzine in phobic anxiety: a controlled trial.Psychol Med. 1973 Feb;3(1):120-4. doi: 10.1017/s0033291700046419. Psychol Med. 1973. PMID: 4571145 Clinical Trial. No abstract available.
-
Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.Psychiatr Clin North Am. 1985 Mar;8(1):49-62. Psychiatr Clin North Am. 1985. PMID: 2859580 Review.
-
A clinical overview of monoamine oxidase inhibitors.Psychosomatics. 1985 Mar;26(3):240-6, 251. doi: 10.1016/S0033-3182(85)72877-0. Psychosomatics. 1985. PMID: 3887453 Review. No abstract available.
Cited by
-
The interaction of psychopharmacology and psychoanalysis in the borderline patient.Psychiatr Q. 1980 Winter;52(4):240-50. doi: 10.1007/BF01080285. Psychiatr Q. 1980. PMID: 6113616 Review. No abstract available.
-
Pharmacotherapy for social anxiety disorder (SAnD).Cochrane Database Syst Rev. 2017 Oct 19;10(10):CD001206. doi: 10.1002/14651858.CD001206.pub3. Cochrane Database Syst Rev. 2017. PMID: 29048739 Free PMC article.
-
Editorial: New look at monoamine oxidase inhibitors.Br Med J. 1976 Jul 10;2(6027):69. doi: 10.1136/bmj.2.6027.69. Br Med J. 1976. PMID: 1276813 Free PMC article. No abstract available.
-
Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine.Psychopharmacology (Berl). 1994 Jun;115(1-2):128-34. doi: 10.1007/BF02244762. Psychopharmacology (Berl). 1994. PMID: 7862884 Clinical Trial.
-
A risk-benefit assessment of buspirone in the treatment of anxiety disorders.Drug Saf. 1997 Feb;16(2):118-32. doi: 10.2165/00002018-199716020-00004. Drug Saf. 1997. PMID: 9067123 Review.